https://www.prnewswire.com/news-releases/findings-published-in-jama-oncology-demonstrate-superiority-of-mridian-mri-guidance-in-stereotactic-body-radiotherapy-sbrt-for-localized-prostate-cancer-301720570.html
/PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) today announced that findings from the phase III randomized controlled MIRAGE trial (NCT04384770) were published...
Create an account or login to join the discussion